MR编号 | NL/H/4569/001 |
---|
药品名称 | Ondansetron Accord 2 mg/ml, |
---|
活性成分 | - Ondansetron dihydrochloride 2.0 mg/ml
|
---|
剂型 | Solution for injection/infusion |
---|
上市许可持有人 | Accord Healthcare B.V.
Winthontlaan 200
3526 KV Utrecht
The Netherlands |
---|
参考成员国 - 产品名称 | Netherlands (NL) |
---|
互认成员国 - 产品名称 | - United Kingdom (Northern Ireland) (XI)
- Germany (DE)
Ondasetron Accord 2mg/mL Injektionslösung - Denmark (DK)
- Belgium (BE)
- Ireland (IE)
- Austria (AT)
Ondansetron Accord 2 mg/ml Injektions- oder Infusionslösung - Spain (ES)
- Portugal (PT)
- Italy (IT)
- Sweden (SE)
Ondansetron Accord - Norway (NO)
- Finland (FI)
- Poland (PL)
Ondansetron Accord 2 mg/ml - Latvia (LV)
Ondansetron Accord 2 mg/ml šķīdums injekcijām vai infūzijām - Estonia (EE)
- Cyprus (CY)
ONDANSETRON ACCORD 2MG/ML - Slovakia (SK)
Ondasetron Accord 2mg/mL, injekčný roztok - Slovenia (SI)
- Lithuania (LT)
Ondansetron Accord 2 mg/ml injekcinis / infuzinis tirpalas - Czechia (CZ)
- Bulgaria (BG)
|
---|
许可日期 | 2009/11/06 |
---|
最近更新日期 | 2024/09/10 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:[not specified]
- TypeLevel2:[not specified]
- TypeLevel3:[not specified]
- TypeLevel4:[not specified]
- TypeLevel5:[not specified]
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|